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Introduction
The immune system, which is the self-defense system of
the body, occasionally responds in a manner that is
harmful to the body. The incidence and severity of aller-
gies caused by cedar pollen, house dust, egg protein, and
many others are increasing and have recently become a
serious social problem. We have previously developed
an original in vitro system for inducing human IgE anti-
body specific to a designated antigen that can be used
to study various allergic reaction [1]. In this study, we
attempted to improve this system to stimulate IgE levels
in its medium to provide a highly sensitive screening
method.
Experimental
The original in vitro IgE-inducing system was established
using lymphocytes and plasma from donors which were
not naturally immunized with allergens. The original sys-
tem contained ERDF supplemented with fetal bovine
serum (final concentration, 5%) and contained human
plasma (10%) as an essential component. Human periph-
eral blood lymphocytes and plasma were obtained by
density-gradient centrifugation at 400 × g for 30 min
with cell separation medium, Ficoll-Paque™ Plus. This
system also included allergen (100 ng/ml), interleukins
(IL-) 2, 4, and 6 (10 ng/ml each) and muramyl dipeptide
(MDP, 10 μg/ml), as described previously [2]. Human
lymphocytes were cultured in 96- or 24-well plates at
a final density of 1 × 106 cells/ml in the medium and
incubated in a CO2 incubator at 37°C for 10 days. During
the 10 days, IgE was specifically secreted into the
medium.
Results and discussion
Effects of human plasma and interleukins on human IgE
induction
The necessity for inclusions of human plasma and inter-
leukins was shown, when human lymphocytes and
plasma from donors which were not naturally immunized
with allergens were used. For the induction of IgE,
human lymphocytes and plasma obtained from the same
donor were required [2]. Addition of IL-2, 4 and 6
induced IgE. Elimination of each of these three interleu-
kins from the medium resulted in no induction of IgE
(data not shown). From these results, IL-2, 4 and 6 are
considered to be essential factors to initially immunize
lymphocytes with allergens, when lymphocytes and
plasma from donors not naturally immunized with
allergens were used. We next attempted to improve this
system to stimulate IgE levels in the medium to provide
a highly sensitive screening method.
Effects of elimination of IL-2 from the medium on human
IgE production
In this study, the lymphocytes and plasma of donors
naturally immunized with various allergens were used.
Therefore, the IgE level of the control was high, i.e.,
more than 300 ng/ml, as shown in Table 1. Elimination
of IL-2 from the medium resulted in the induction of
higher IgE levels compared with medium containing IL-2
(Table 1). These data indicate that elimination of IL-2
from the medium induced higher IgE levels when human
lymphocytes and plasma obtained from naturally immu-
nized donors were used. Furthermore, strawberry extract
in the media containing Cryj1 and Derf2 decreased the
secreted IgE levels by 38% and 24%, respectively. There is
a possibility that strawberries may alleviate allergies.
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In summary, elimination of IL-2 from the IgE-inducing
system medium increased the IgE induction level when
human lymphocytes and plasma obtained from donors
naturally immunized with allergens were used. The level
of about 1 μg/ml IgE reported to be secreted in this
study may be the highest compared with those reported
elsewhere. The original and improved systems for human
IgE production are considered to be of profound use
for studying allergy mechanisms and surveying allergy-
alleviating products, respectively.
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Table 1 Effects of various additives on IgE productivity
Medium IgE productivity (ng/ml)
Control (ERDF + hPlasma + FBS) 319 ± 19
+ IL-2 + IL-4 + IL-6 + MDP + Cryj1 356 ± 85
+ IL-4 + IL-6 + MDP + Cryj1 549 ± 189
+ IL-4 + IL-6 + MDP + Cryj1 + strawberry extract 341 ± 55
+ IL-4 + IL-6 + MDP + Derf2 660 ± 172
+ IL-4 + IL-6 + MDP + Derf2 + strawberry extract 499 ± 167
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